Skip to main content
Top
Published in: Journal of Cancer Education 4/2023

17-12-2022 | Fatty Liver

Factors Associated with Awareness and Knowledge of Nonalcoholic Fatty Liver Disease, a Liver Cancer Etiological Factor, Among Chinese Young Adults

Authors: Yi Du, Dejun Su, Kendra L. Ratnapradipa, Jianghu Dong, Fedja A. Rochling, Paraskevi A. Farazi

Published in: Journal of Cancer Education | Issue 4/2023

Login to get access

Abstract

Purpose

Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), a liver cancer etiological factor, among Chinese young adults (CYA), there is a lack of study assessing awareness and knowledge of NAFLD among them. This study aimed to assess awareness and knowledge of NAFLD, and identify the factors associated with awareness and knowledge of NAFLD among CYA. We conducted a survey to assess awareness and knowledge of NAFLD among students who enrolled in one university undergraduate program in 2018, 2019, and 2020 through a newly developed web-based, self-administered questionnaire. The outcomes included awareness of NAFLD and knowledge score of NAFLD. We conducted unadjusted and adjusted analyses of associated factors with these outcomes. A total of 1373 students participated in the survey. Of all participants, 26.2% reported that they had heard of NAFLD, 7.7% reported that they had heard of lean NAFLD, and 11.1% received ≥ 20 points in the knowledge section of NAFLD. The mean and median scores were 9.35 (Std = 7.67) and 9 (range 0–27). Factors associated with having awareness and knowledge (≥ 20 points) of NAFLD included medical background, high medical knowledge level, and family history of NAFLD. There was low NAFLD awareness and knowledge among CYA aged 18 to 25 years. Our findings point to the need to develop an educational intervention for CYA to improve their NAFLD awareness and knowledge. Further studies should include information on physical activity and dietary habits to test whether NAFLD awareness and knowledge impact those habits.
Appendix
Available only for authorised users
Literature
1.
go back to reference Younossi ZM, Koenig AB, Abdelatif D et al (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol 64:73–84CrossRef Younossi ZM, Koenig AB, Abdelatif D et al (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol 64:73–84CrossRef
2.
go back to reference Karim MA, Singal AG, Kum HC et al (2022) Clinical characteristics and outcomes of nonalcoholic fatty liver disease–associated hepatocellular carcinoma in the United States Karim MA, Singal AG, Kum HC et al (2022) Clinical characteristics and outcomes of nonalcoholic fatty liver disease–associated hepatocellular carcinoma in the United States
3.
go back to reference Zhou J, Zhou F, Wang W et al (2020) Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatol 71:1851–1864CrossRef Zhou J, Zhou F, Wang W et al (2020) Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatol 71:1851–1864CrossRef
4.
go back to reference Wu Y, Zheng Q, Zou B et al (2020) The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int 14:259–269CrossRefPubMed Wu Y, Zheng Q, Zou B et al (2020) The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int 14:259–269CrossRefPubMed
6.
go back to reference Zhou F, Zhou J, Wang W et al (2019) Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatol 70:1119–1133CrossRef Zhou F, Zhou J, Wang W et al (2019) Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatol 70:1119–1133CrossRef
8.
go back to reference Estes C, Anstee QM, Arias-Loste MT et al (2018) Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol 69:896–904CrossRefPubMed Estes C, Anstee QM, Arias-Loste MT et al (2018) Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol 69:896–904CrossRefPubMed
10.
go back to reference Painter JE, Borba CP, Hynes M et al (2008) The use of theory in health behavior research from 2000 to 2005: a systematic review. Ann Behav Med 35:358–362CrossRefPubMed Painter JE, Borba CP, Hynes M et al (2008) The use of theory in health behavior research from 2000 to 2005: a systematic review. Ann Behav Med 35:358–362CrossRefPubMed
11.
go back to reference Zhang W, Chao S, Chen S et al (2019) Awareness and knowledge of nonalcoholic fatty liver disease among office employees in Beijing. China Dig Dis Sci 64:708–717CrossRefPubMed Zhang W, Chao S, Chen S et al (2019) Awareness and knowledge of nonalcoholic fatty liver disease among office employees in Beijing. China Dig Dis Sci 64:708–717CrossRefPubMed
12.
go back to reference Chen S, Chao S, Konerman M et al (2019) Survey of nonalcoholic fatty liver disease knowledge, nutrition, and physical activity patterns among the general public in Beijing, China. Dig Dis Sci Chen S, Chao S, Konerman M et al (2019) Survey of nonalcoholic fatty liver disease knowledge, nutrition, and physical activity patterns among the general public in Beijing, China. Dig Dis Sci
13.
go back to reference Leung CM, Lai LS, Wong WH et al (2009) Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol 24:1786–1790CrossRefPubMed Leung CM, Lai LS, Wong WH et al (2009) Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol 24:1786–1790CrossRefPubMed
14.
go back to reference Goh GB, Kwan C, Lim SY et al (2016) Perceptions of non-alcoholic fatty liver disease - an Asian community-based study. Gastroenterol Rep (Oxf) 4:131–135CrossRefPubMed Goh GB, Kwan C, Lim SY et al (2016) Perceptions of non-alcoholic fatty liver disease - an Asian community-based study. Gastroenterol Rep (Oxf) 4:131–135CrossRefPubMed
16.
go back to reference Textor C (2021) Per capita gross domestic product (GDP) in China in 2019, by province or region. In. Feb 15 Textor C (2021) Per capita gross domestic product (GDP) in China in 2019, by province or region. In. Feb 15
17.
go back to reference Younossi Z, Anstee QM, Marietti M et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11–20CrossRefPubMed Younossi Z, Anstee QM, Marietti M et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11–20CrossRefPubMed
18.
go back to reference Li Y, Teng D, Shi X et al (2020) Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ 369:m997CrossRefPubMedPubMedCentral Li Y, Teng D, Shi X et al (2020) Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ 369:m997CrossRefPubMedPubMedCentral
19.
go back to reference Wang M, Xu PS, Liu W et al (2020) Prevalence and changes of BMI categories in China and related chronic diseases: cross-sectional National Health Service Surveys (NHSSs) from 2013 to 2018. EClinicalMedicine 26:100521CrossRefPubMedPubMedCentral Wang M, Xu PS, Liu W et al (2020) Prevalence and changes of BMI categories in China and related chronic diseases: cross-sectional National Health Service Surveys (NHSSs) from 2013 to 2018. EClinicalMedicine 26:100521CrossRefPubMedPubMedCentral
20.
go back to reference Janevska D, Chaloska-Ivanova V, Janevski V (2015) Hepatocellular carcinoma: risk factors, diagnosis and treatment. Open Access Maced J Med Sci 3:732–736CrossRefPubMedPubMedCentral Janevska D, Chaloska-Ivanova V, Janevski V (2015) Hepatocellular carcinoma: risk factors, diagnosis and treatment. Open Access Maced J Med Sci 3:732–736CrossRefPubMedPubMedCentral
21.
go back to reference Fan M, Hong J, Cheung PN et al (2020) Knowledge and attitudes towards obesity and bariatric surgery in Chinese nurses. Obes Surg 30:618–629CrossRef Fan M, Hong J, Cheung PN et al (2020) Knowledge and attitudes towards obesity and bariatric surgery in Chinese nurses. Obes Surg 30:618–629CrossRef
23.
go back to reference Arshad T, Paik JM, Biswas R et al (2021) Nonalcoholic fatty liver disease prevalence trends among adolescents and young adults in the United States, 2007–2016. Hepatol Commun 5:1676–1688CrossRefPubMedPubMedCentral Arshad T, Paik JM, Biswas R et al (2021) Nonalcoholic fatty liver disease prevalence trends among adolescents and young adults in the United States, 2007–2016. Hepatol Commun 5:1676–1688CrossRefPubMedPubMedCentral
24.
go back to reference Alqahtani SA, Paik JM, Biswas R et al (2021) Poor awareness of liver disease among adults with NAFLD in the United States. Hepatol Commun 5:1833–1847CrossRefPubMedPubMedCentral Alqahtani SA, Paik JM, Biswas R et al (2021) Poor awareness of liver disease among adults with NAFLD in the United States. Hepatol Commun 5:1833–1847CrossRefPubMedPubMedCentral
25.
go back to reference Gan Q, Xu P, Yang T et al (2021) Sugar-sweetened beverage consumption status and its association with childhood obesity among Chinese children aged 6–17 years. Nutrients 13 Gan Q, Xu P, Yang T et al (2021) Sugar-sweetened beverage consumption status and its association with childhood obesity among Chinese children aged 6–17 years. Nutrients 13
Metadata
Title
Factors Associated with Awareness and Knowledge of Nonalcoholic Fatty Liver Disease, a Liver Cancer Etiological Factor, Among Chinese Young Adults
Authors
Yi Du
Dejun Su
Kendra L. Ratnapradipa
Jianghu Dong
Fedja A. Rochling
Paraskevi A. Farazi
Publication date
17-12-2022
Publisher
Springer US
Keyword
Fatty Liver
Published in
Journal of Cancer Education / Issue 4/2023
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-022-02246-9

Other articles of this Issue 4/2023

Journal of Cancer Education 4/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine